Yes, ChampionX investors are claiming they were misled about material information during a critical period when company executives were repurchasing shares. According to class action lawsuits filed by multiple law firms, ChampionX Corporation concealed acquisition offers from SLB (Schlumberger Limited) while simultaneously buying back approximately 216,000 shares for $6.9 million in March 2024. The timing raises serious questions: executives knew SLB had offered between $36.70 and $40.29 per share, yet the company was repurchasing shares at an average price of $31.80 per share—roughly 13 to 26 percent lower than the hidden acquisition bids.
The class period runs from February 29, 2024, through April 1, 2024, affecting investors who sold ChampionX stock (NASDAQ: CHX) during this window. When the SLB merger finally closed on July 16, 2025, shareholders received $40.58 per share—far exceeding what investors got when they sold during the blackout period. The lawsuits allege securities fraud and breach of fiduciary duty, claiming that ChampionX executives either should have abstained from stock repurchases or immediately disclosed the pending acquisition offers to the market.
Table of Contents
- What Triggered the Blackout Period Allegations?
- How Were Shareholders Harmed by the Price Disparity?
- The Acquisition Offers and What They Reveal
- Which Law Firms Are Pursuing ChampionX Investors’ Claims?
- The Insider Trading and Market Transparency Problem
- Timeline from Offers to Merger Completion
- What Happens Next and What Changes May Result
- Conclusion
What Triggered the Blackout Period Allegations?
The core allegation hinges on timing and information asymmetry. During early 2024, SLB was pursuing ChampionX through multiple acquisition offers, yet company leadership reportedly kept this development confidential. Meanwhile, ChampionX’s repurchase program continued in March 2024, creating what securities lawyers call a “blackout” scenario—a period when insiders possess material non-public information and any trading becomes problematic.
The company repurchased 216,000 shares for $6.9 million during this exact window, benefiting the company at the expense of shareholders who sold into what they believed was ordinary market activity. This scenario resembles other insider trading cases where executives time share repurchases to minimize the company’s dilution while concealing knowledge of transformative corporate events. For comparison, when pharmaceutical companies learn of failed clinical trials before announcing them publicly, similar blackout protocols kick in. The difference in ChampionX’s case is that the repurchase program allegedly continued despite executives knowing of multiple acquisition offers on the table—offers that would have dramatically changed the stock’s valuation.
How Were Shareholders Harmed by the Price Disparity?
The financial harm to class period sellers is stark and quantifiable. Investors who sold ChampionX shares between February 29 and April 1, 2024, received an average price of approximately $31.80 per share in the market. When the SLB deal closed fifteen months later, those same shares were worth $40.58 per share—a 27.6 percent difference. A shareholder who sold 1,000 shares during the class period at $31.80 lost roughly $8,780 in value compared to holding through the merger close. The lawsuit claims this harm was preventable.
Had ChampionX disclosed SLB’s acquisition offers—which ranged as high as $40.29 per share—the stock price would presumably have reflected that information. Instead, shareholders sold without knowing that the company leadership was already aware of a buyer willing to pay significantly more. This creates a fiduciary duty problem: company executives repurchasing shares while concealing information about a substantially higher-priced acquisition violates the principle that insiders must act in shareholders’ interests, not extract advantages from information asymmetry. One important limitation: shareholders must prove they actually sold during the class period and can document their losses. The deadline for lead plaintiff designation is July 14, 2026, so time is a critical factor for potential claimants.
The Acquisition Offers and What They Reveal
SLB’s acquisition pursuit involved at least four separate offers, ranging from $36.70 to $40.29 per share. This wasn’t a surprise bid that materialized overnight—it was a series of escalating proposals over multiple weeks. The progression of offers suggests active negotiation, with SLB signaling its growing willingness to pay more. The fact that the final merger price settled at $40.58 per share indicates the offers were serious and closely aligned with SLB’s actual valuation of the company.
The repurchase timing becomes especially problematic in this light. Between the first and final offers from SLB, ChampionX continued buying back shares at $31.80 average price. This spread—$40.29 at the high end of offers versus $31.80 in repurchases—represents the window where shareholders were harmed. The company essentially locked in lower prices for share retirement while executives knew the company was actually worth substantially more in an acquisition context. For investors who sold during this period, they received prices that reflected neither the acquisition reality nor the company’s intrinsic value.
Which Law Firms Are Pursuing ChampionX Investors’ Claims?
Multiple established securities litigation firms have filed class actions on behalf of ChampionX shareholders. Berger Montague PC, known for major securities fraud recoveries, leads one of the primary actions. Bronstein, Gewirtz & Grossman LLC filed a parallel complaint. Robbins LLP and Schall Law Firm have also stepped in to represent investors. This multi-firm approach is typical for high-profile mergers where investor harm is significant and damages are quantifiable.
The presence of multiple quality law firms creates both advantages and complications for claimants. On one hand, competition between firms typically improves service and may accelerate settlement negotiations. On the other hand, claimants must eventually deal with consolidation, as courts generally appoint a single lead plaintiff and lead counsel to manage the litigation. The lead plaintiff deadline of July 14, 2026, is critical—investors who want to participate in determining the lawsuit’s direction must submit their proposals by this date. After that, the court selects a representative plaintiff to guide the case forward.
The Insider Trading and Market Transparency Problem
ChampionX’s alleged conduct raises broader concerns about when executives should abstain from trading during merger negotiations. Securities law generally requires officers and directors to refrain from trading while in possession of material non-public information. Some companies implement automatic blackout periods when major transactions are under discussion. The question in ChampionX’s case becomes: did the company and its executives follow these protocols, or did they actively repurchase shares despite knowing acquisition offers were on the table? The lawsuit allegations suggest aggressive behavior rather than inadvertent neglect. The company didn’t just abstain from selling shares (which would be prudent) or announce the acquisition offers (which would be transparent)—it actively repurchased shares at depressed prices while concealing the information that would have justified much higher valuations.
This distinction matters legally. It transforms the case from a narrow technical violation into an affirmative misrepresentation, where insiders benefited at shareholders’ expense while withholding price-relevant information. One critical warning: not every shareholder who sold during this period may have legal standing. The class typically includes only investors who sold during February 29 to April 1, 2024, at prices below what would have been justified by the acquisition offer disclosure. Shareholders who held through the merger or sold after April 1, 2024, are generally excluded.
Timeline from Offers to Merger Completion
The SLB acquisition offers began arriving in late February 2024, with the first concrete proposal emerging around the time the class period commenced on February 29, 2024. By March 2024—when ChampionX conducted its stock repurchase of 216,000 shares—negotiation was clearly underway. SLB escalated its offer to $40.29 per share as discussions progressed, but the market didn’t learn about any of this until the deal was publicly announced.
The merger eventually closed on July 16, 2025—about sixteen months after the class period ended. During those sixteen months, shareholders who had sold at $31.80 watched the stock climb toward the $40.58 final price, unable to participate in the gain because they had already exited their positions based on incomplete information. The extended timeline between the class period and merger close also creates practical complications: shareholders need to locate old trading confirmations and broker statements, some brokerage accounts have been transferred or closed, and the passage of time naturally complicates evidence gathering.
What Happens Next and What Changes May Result
If the class action succeeds, ChampionX will likely face a substantial settlement or judgment. The law firms pursuing these claims typically recover 15-30 percent of the total award in legal fees, but claimants may recover 50-80 percent of their documented losses depending on the final verdict or settlement amount. The case could also trigger regulatory scrutiny from the Securities and Exchange Commission into ChampionX’s trading practices during the negotiation period.
Beyond this specific case, ChampionX’s situation may reinforce the importance of strict information controls during M&A negotiations. Public companies may respond by implementing more rigorous trading blackouts and disclosure protocols. For investors, the lawsuit serves as a reminder that share repurchases during merger negotiations are inherently suspicious when major bids are on the table. The case also highlights why investors should pay attention to unusual trading activity, insider buying or selling patterns, and SEC filings that mention negotiations or acquisition interest—these can be early warning signs that material information is being withheld.
Conclusion
The ChampionX class action lawsuit presents a straightforward allegation: executives knew acquisition offers worth $40+ per share were on the table, yet allowed the company to repurchase shares at $31.80 per share while keeping that information secret. Investors who sold during the February 29 to April 1, 2024 class period received prices that didn’t reflect the company’s true acquisition value. Multiple law firms have filed claims on their behalf, and the lead plaintiff deadline is July 14, 2026—a critical deadline for anyone who sold ChampionX stock during the blackout period.
If you sold ChampionX shares during the class period, documenting your trades and losses is essential. Contact one of the law firms handling the case or consult with a securities attorney to understand your eligibility and potential recovery. As the litigation progresses toward resolution, shareholder recoveries will depend on the strength of evidence linking the stock repurchases to insider knowledge of the acquisition offers. The case also serves as a cautionary tale about the importance of market transparency and the consequences when executives prioritize company interests over shareholder protection during critical corporate events.